Insider · CIK 0001384859
Kolchinsky Peter
Reports to the SEC for 76 companies · BOSTON, MA
Transactions
50
Companies
76
Filings
10
CIK
0001384859
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-06-29 | POINT Biopharma Global Inc.A Award | +$2.09M |
| 2021-06-24 | POINT Biopharma Global Inc.A Award | +$8.89M |
| 2021-06-17 | Forma Therapeutics Holdings, Inc.A Award | — |
| 2021-06-17 | Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-08-18 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2020-06-23 | Forma Therapeutics Holdings, Inc.C Conversion | — |
| 2020-06-23 | Forma Therapeutics Holdings, Inc.P Purchase | +$80M |
| 2020-06-23 | Forma Therapeutics Holdings, Inc.Series D Redeemable Convertible Preferred StockC Conversion | — |
| 2020-06-18 | Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-01-23 | Synthorx, Inc.U Disposition from Tender | −$661M |
| 2020-01-23 | Synthorx, Inc.Stock Option (right to buy)D Disposition to Issuer | −$853K |
| 2020-01-23 | Synthorx, Inc.Stock Option (right to buy)D Disposition to Issuer | −$1.71M |
| 2019-12-02 | Dicerna Pharmaceuticals IncS Sale | −$3.43M |
| 2019-11-29 | Dicerna Pharmaceuticals IncS Sale | −$3.34M |
| 2019-11-27 | Dicerna Pharmaceuticals IncS Sale | −$8.86M |
| 2019-11-26 | Dicerna Pharmaceuticals IncS Sale | −$5.65M |
| 2019-11-25 | Dicerna Pharmaceuticals IncS Sale | −$8.69M |
| 2019-11-22 | Dicerna Pharmaceuticals IncS Sale | −$4.45M |
| 2019-11-21 | Dicerna Pharmaceuticals IncS Sale | −$8.08M |
| 2019-11-20 | Dicerna Pharmaceuticals IncS Sale | −$6.09M |
| 2019-11-19 | Dicerna Pharmaceuticals IncS Sale | −$9.5M |
| 2019-08-15 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2019-06-20 | Dicerna Pharmaceuticals IncDirector Stock Option (right to buy)A Award | — |
| 2019-06-07 | Synthorx, Inc.Stock Option (right to buy)A Award | — |
| 2018-12-11 | Synthorx, Inc.Series C Preferred StockC Conversion | — |
| 2018-12-11 | Synthorx, Inc.C Conversion | — |
| 2018-12-11 | Synthorx, Inc.C Conversion | — |
| 2018-12-11 | Synthorx, Inc.P Purchase | +$50M |
| 2018-12-11 | Synthorx, Inc.Series B Preferred StockC Conversion | — |
| 2018-12-06 | Synthorx, Inc.Stock Option (right to buy)A Award | — |
| 2018-11-08 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$1.6M |
| 2018-11-07 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$3.69M |
| 2018-11-06 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$3.64M |
| 2018-11-05 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$920K |
| 2018-11-02 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$2.37M |
| 2018-11-01 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$2.41M |
| 2018-10-31 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$2.4M |
| 2018-10-30 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$3.47M |
| 2018-08-13 | WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award | — |
| 2018-06-21 | Dicerna Pharmaceuticals IncDirector Stock Option (right to buy)A Award | — |
| 2018-03-23 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$611K |
| 2018-03-21 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$405K |
| 2018-03-21 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$546K |
| 2018-03-21 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$345K |
| 2018-03-21 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$726K |
| 2018-03-20 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$759K |
| 2018-03-20 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$616K |
| 2018-03-20 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$550K |
| 2018-03-19 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$432K |
| 2018-03-19 | Dicerna Pharmaceuticals IncD Disposition to Issuer | −$1.07M |
Recent filings
- 4Kolchinsky Peter0001104659-21-087618SEC(opens sec.gov)
- 4Kolchinsky Peter0001104659-21-085291SEC(opens sec.gov)
- 4Kolchinsky Peter0000899243-21-025088SEC(opens sec.gov)
- 4Kolchinsky Peter0000899243-20-023092SEC(opens sec.gov)
- 4Kolchinsky Peter0000899243-20-017602SEC(opens sec.gov)
- 4Kolchinsky Peter0000899243-20-017430SEC(opens sec.gov)
- 4Kolchinsky Peter0001209191-20-004921SEC(opens sec.gov)
- 4Kolchinsky Peter0001104659-19-068984SEC(opens sec.gov)
- 4Kolchinsky Peter0001104659-19-067705SEC(opens sec.gov)
- 4Kolchinsky Peter0001104659-19-066292SEC(opens sec.gov)
Companies
- 4D Molecular Therapeutics, Inc.10% OwnerFDMT
- 89bio, Inc.Director, 10% OwnerETNB
- ACHILLION PHARMACEUTICALS INCFormer 10% Owner, See FN(5)(6)
- Aclaris Therapeutics, Inc.10% OwnerACRS
- Acrivon Therapeutics, Inc.Director, 10% OwnerACRV
- Acumen Pharmaceuticals, Inc.Director, 10% OwnerABOS
- Adicet Bio, Inc.10% OwnerACET
- Akouos, Inc.10% Owner
- AN2 Therapeutics, Inc.10% OwnerANTX
- ARADIGM CORP10% Owner
- ARS Pharmaceuticals, Inc.Director, 10% OwnerSPRY
- Artiva Biotherapeutics, Inc.Director, 10% OwnerARTV
- ARVINAS, INC.Former 10% OwnerARVN
- Bicara Therapeutics Inc.Director, 10% OwnerBCAX
- BIOSPECIFICS TECHNOLOGIES CORP10% Owner
- Black Diamond Therapeutics, Inc.DirectorBDTX
- Boundless Bio, Inc.10% OwnerBOLD
- Cardiff Oncology, Inc.10% OwnerCRDF
- Cidara Therapeutics, Inc.Director, 10% OwnerCDTX
- Climb Bio, Inc.Director, 10% OwnerCLYM
- Cytek Biosciences, Inc.Director, 10% OwnerCTKB
- DERMA SCIENCES, INC.Fmr 10% Owner - See Fn (1)-(5)
- Dicerna Pharmaceuticals IncDirector
- DICE Therapeutics, Inc.Former 10% owners and Director
- Dyne Therapeutics, Inc.10% OwnerDYN
- Eidos Therapeutics, Inc.10% Owner
- Eiger BioPharmaceuticals, Inc.10% Owner
- Enliven Therapeutics, Inc.Former 10% ownerELVN
- Evommune, Inc.DirectorEVMN
- Forma Therapeutics Holdings, Inc.10% Owner
- Freenome, Inc.Director, 10% OwnerFRNM
- Fulcrum Therapeutics, Inc.10% OwnerFULC
- G1 Therapeutics, Inc.Fmr 10% Owner See Footnote (2)
- Hemab Therapeutics Holdings, Inc.10% OwnerCOAG
- Icosavax, Inc.Director, 10% Owner
- Inhibikase Therapeutics, Inc.10% OwnerIKT
- Inhibrx, Inc.10% Owner
- Inozyme Pharma, Inc.10% Owner
- iTeos Therapeutics, Inc.Former 10% Owner
- Iterum Therapeutics plc10% OwnerITRM
- Jade Biosciences, Inc.10% OwnerJBIO
- Janux Therapeutics, Inc.Director, 10% OwnerJANX
- KALA BIO, Inc.10% OwnerKALA
- KalVista Pharmaceuticals, Inc.Director, 10% Owner
- LENZ Therapeutics, Inc.Director, 10% OwnerLENZ
- Mineralys Therapeutics, Inc.DirectorMLYS
- Nkarta, Inc.Director, 10% OwnerNKTX
- Orchard Therapeutics plcDirector, 10% Owner
- Pandion Therapeutics, Inc.10% Owner
- Parabilis Medicines, Inc.Director, 10% OwnerPBLS
- PepGen Inc.Director, 10% OwnerPEPG
- Phathom Pharmaceuticals, Inc.10% OwnerPHAT
- PMV Pharmaceuticals, Inc.10% OwnerPMVP
- POINT Biopharma Global Inc.Director, Chief Executive Officer
- Prelude Therapeutics Inc10% OwnerPRLD
- Ra Pharmaceuticals, Inc.Director, 10% Owner
- Research Alliance Corp. IIDirector, Chief Executive Officer
- RHYTHM PHARMACEUTICALS, INC.Former 10% OwnerRYTM
- RxSight, Inc.10% OwnerRXST
- SANGAMO THERAPEUTICS, INCFormer 10% OwnerSGMOQ
- Satsuma Pharmaceuticals, Inc.Former 10% Owner
- scPharmaceuticals Inc.10% OwnerSCPH
- Septerna, Inc.Director, 10% OwnerSEPN
- SEQUENOM INC10% Owner
- Sionna Therapeutics, Inc.Director, 10% OwnerSION
- Solid Biosciences Inc.10% OwnerSLDB
- SpyGlass Pharma, Inc.Director, 10% OwnerSGP
- Synthorx, Inc.Director, 10% Owner
- TG THERAPEUTICS, INC.10% OwnerTGTX
- Tyra Biosciences, Inc.Director, 10% OwnerTYRA
- Vaxcyte, Inc.10% OwnerPCVX
- Verastem, Inc.10% OwnerVSTM
- Viridian Therapeutics, Inc.\DE10% OwnerVRDN
- Vor Biopharma Inc.10% OwnerVOR
- Wave Life Sciences, Inc.Director, 10% OwnerWVE
- Werewolf Therapeutics, Inc.10% OwnerHOWL
Address
C/O RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA, 02116